Lexicon Pharmaceuticals, Inc. (LXRX)
1.315
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Novavax, Inc. | 42.44M |
| Viemed Healthcare, Inc. | 5.037M |
| Agenus, Inc. | 6.683M |
| Curis, Inc. | 4.482M |
| LadRx Corp. | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.83M |
| Cash from Investing (Quarterly) | 52.12M |
| Free Cash Flow | -73.89M |
| Free Cash Flow Per Share (Quarterly) | -0.0656 |
| Free Cash Flow to Equity (Quarterly) | -27.33M |
| Free Cash Flow to Firm (Quarterly) | -21.68M |
| Free Cash Flow Yield | -15.50% |